New Drug Approvals in China: An International Comparative Analysis, 2019-2023
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s514132 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Yilong Yan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Drug Approval. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
- School of Pharmaceutical Sciences, Capital Medical University, Beijing, People's Republic of China.
- Data Center, Kangzhou Pharmaceutical Big Data Development and Application Research Institute, Chongqing, People's Republic of China.
- Data Center, Chongqing Kangzhou Big Data (Group) Co., Ltd, Chongqing, People's Republic of China.
- Party Committee Office, Beijing Tiantan Hospital, Capital Medical University, Beijing, People's Republic of China.
- School of Medicine, Tsinghua University, Beijing, People's Republic of China.
ORCID-Profile: Yilong Yan
Zitieren
APA
Yan, Y., Guo, X., Li, Z., Shi, W., Long, M., Yue, X., Kong, F., & Zhao, Z. (2025). New Drug Approvals in China: An International Comparative Analysis, 2019-2023. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s514132
Vancouver
Yan Y, Guo X, Li Z, Shi W, Long M, Yue X, et al. New Drug Approvals in China: An International Comparative Analysis, 2019-2023. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s514132
BibTeX
@article{Yan2025,
author = {Yan, Yilong and Guo, Xiangyu and Li, Ziming and Shi, Weilin and Long, Min and Yue, Xiaolin and Kong, Fanpu and Zhao, Zhigang},
title = {New Drug Approvals in China: An International Comparative Analysis, 2019-2023},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s514132}
}
EUVIMED